Rituxan Hycela

Active Ingredient(s): Hyaluronidase + Rituximab
FDA Approved: * June 22, 2017
Pharm Company: * GENENTECH INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Rituxan Hycela Overview

Rituximab, sold under the brand name Rituxan, is a medication used to treat certain autoimmune diseases and types of cancer.[9] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.[9][10][11][...

Read more Rituxan Hycela Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rituximab

Recent Rituxan Hycela Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Hyaluronidase + Rituximab
  • Injection: 1400mg And 23400units/11.7ml, 1600mg And 26800units/13.4ml
  • Solution: 1400mg And 23400units/11.7ml, 1600mg And 26800units/13.4ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rituxan Hycela: (2 results)

Sorted by National Drug Code
  • 50242-108 Rituxan Hycela Subcutaneous Injection, Solution by Genentech, Inc.
  • 50242-109 Rituxan Hycela Subcutaneous Injection, Solution by Genentech, Inc.

Drugs with one or more similar ingredients: (20 results)